Stage I adenocarcinoma of the cervix: Does lesion size affect treatment options and prognosis?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 5, 1998, Pages 431-435

  Silver, David F ^a   Hempling, Ronald E ^a   Piver, M Steven ^a   Recio, Fernando O ^a   Eltabbakh, Gamal H ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Cervical cancer; Lesion size; Patient age; Tumor grade

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROGNOSIS; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0031755363     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199810000-00001     Document Type: Article

References (23)

1. Mikuta JJ, Celebre JA. Adenocarcinoma of the cervix. Obstet Gynecol 1969;33:753-6.
2. Rutledge FN, Galakatos AE, Wharton, et al. Adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 1975;122:236-45.
3. Leminen A, Paavonen J, Forss M, et al. Adenocarcinoma of the uterine cervix. Cancer 1990;65:53-9.
4. Goodman HM, Buttlar CA, Niloff JM, et al. Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence. Gynecol Oncol 1989;33:241-7.
5. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975;46:507-10.
6. Piver MS, Marchetti DL, Patton T, et al. Radical hysterectomy and pelvic lymphadenectomy versus radiation therapy for small (
7. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gvnecol 1974;44:265-72.
8. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-7.
9. Moberg PJ, Einhorn N, Silversward C, et al. Adenocarcinoma of the uterine cervix. Cancer 1986;57:407-10.
10. Kleine W, Rau K, Schwoeorer D, et al. Prognosis of adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol 1989;35:145-9.
11. Berek JS, Castaldo TW, Hacker NF, et al. Adenocarcinoma of the uterine cervix. Cancer 1981;48:2734-41.
12. Prempree T, Amornmarn R, Wizenberg MJ. A therapeutic approach to primary adenocarcinoma of the cervix. Cancer 1985;56:1264-8.
13. Saigo PE, Cain JK, Kim WS, et al. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986;57:1584-93.
14. Ireland D, Hardiman P, Monaghan JM. Adenocarcinoma of the uterine cervix: a study of 73 cases. Obstet Gynecol 1985;65:82-5.
15. Hopkins MP, Schmidt RW, Roberts JA, et al. Gland cell carcinoma (adenocarcinoma) of the cervix. Obstet Gynecol 1988;72:789-95.
16. Angel C, DuBeshter B, Lin JY. Clinical management of stage I cervical adenocarcinoma: a 25 year experience. Gynecol Oncol 1992;44:71-8.
17. Tamimi HK, Figge DC. Adenocarcinoma of the uterine cervix. Gynecol Oncol 1982;13:335-44.
18. Berek JS, Hacker NF, Fu Y-S, et al. Adenocarcinoma of the uterine cervix: histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985;65:46-52.
19. Shingleton HM, Gore H, Bradley DH, et al. Adenocarcinoma of the cervix I. clinical evaluation and pathologic features. Am J Obstet Gynecol 1981;139:799-814.
20. Eifel PJ, Morris M, Oswald MJ, et al. Adenocarcinoma of the uterine cervix prognosis and patterns of failure in 367 cases. Cancer 199065:2507-14.
21. Eifel PJ, Burke TW, Delclos L, et al. Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors
22. Hopkins MP, Schmidt RW, Roberts JA, et al. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol 1988;72:915-21.
23. Matthews CM, Burke TW, Tornos C, et al. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients. Gynecol Oncol 199349:19-23.